In a multicentre, double-blind, placebo-controlled phase 2 study (NCT00672074 [15] ), 117 adults undergoing bowel resection were randomised to 0.03 mg/kg IV ipamorelin or placebo twice daily for up to 7 days
Semaglutide GLP-1 has proven to be an effective tool for long-term weight loss, particularly for those dealing with obesity
Although a large number of short-term and medium-term clinical studies support the safety and efficacy of GLP-1RAs, there are insufficient data on the presence of delayed side effects with their long-term (decades) use (Guirguis et al., 2024)
Contrarily, a verdict is the decision made by a judge or jury should the case proceed to court
Common side effects of medical weight loss medications like Semaglutide and Tirzepatide can include nausea, diarrhea, constipation, headache, and fatigue